Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 19, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450, putative | cytochrome P450, family 19, subfamily A, polypeptide 1 | 503 aa | 425 aa | 18.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0087 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0087 | 0 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0245 | 0.6527 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0245 | 0.6527 | 0.6527 |
Schistosoma mansoni | hypothetical protein | 0.0245 | 0.6527 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0245 | 0.6527 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0245 | 0.6527 | 0.6527 |
Plasmodium vivax | hypothetical protein, conserved | 0.0245 | 0.6527 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0087 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0245 | 0.6527 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0087 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0245 | 0.6527 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0245 | 0.6527 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0245 | 0.6527 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.0245 | 0.6527 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0329 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0245 | 0.6527 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0245 | 0.6527 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0245 | 0.6527 | 1 |
Onchocerca volvulus | 0.0245 | 0.6527 | 1 | |
Trypanosoma brucei | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0245 | 0.6527 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0245 | 0.6527 | 0.6527 |
Schistosoma mansoni | brg-1 associated factor | 0.0245 | 0.6527 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0245 | 0.6527 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0087 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0087 | 0 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0245 | 0.6527 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0245 | 0.6527 | 0.6527 |
Leishmania major | hypothetical protein, conserved | 0.0087 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0245 | 0.6527 | 0.6527 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0087 | 0 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0087 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0245 | 0.6527 | 0.6527 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0087 | 0 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0245 | 0.6527 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0245 | 0.6527 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.26 uM | Inhibition of aromatase (unknown origin) in human SKBR3 cells by tritiated water release assay | ChEMBL. | 18271519 |
IC50 (binding) | = 0.26 uM | Inhibition of aromatase (unknown origin) in human SKBR3 cells by tritiated water release assay | ChEMBL. | 18271519 |
Inhibition (binding) | > 50 % | Inhibition of aromatase in SK-BR-3 cells by tritiated water release assay at 2.5 uM | ChEMBL. | 17315855 |
Inhibition (binding) | > 50 % | Inhibition of aromatase in SK-BR-3 cells by tritiated water release assay at 2.5 uM | ChEMBL. | 17315855 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.